专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US09258699B2 Method for route transmission based on single IPv6 address prefix, and wireless device 有权
标题翻译：基于单一IPv6地址前缀的路由传输方法和无线设备
公开(公告)号：US09258699B2
公开(公告)日：2016-02-09
申请号：US14241989
申请日：2012-02-17
申请人： Li Zhao , Tao Lu , Jianfeng Li , Xiaoliang Ma
发明人： Li Zhao , Tao Lu , Jianfeng Li , Xiaoliang Ma
IPC分类号： H04W8/26 , H04W80/04 , H04L29/12 , H04L29/06 , H04W84/18 , H04L12/741 , H04W40/24
CPC分类号： H04W8/26 , H04L45/74 , H04L61/2007 , H04L61/25 , H04L61/6004 , H04L61/6022 , H04L61/6059 , H04L61/6068 , H04L61/6077 , H04L61/6086 , H04L69/16 , H04W40/24 , H04W80/04 , H04W84/18
摘要： The present document provides a method and wireless device for implementing route transmission based on a single IPv6 address prefix. The method includes: when a wireless device succeeds in IPv6-based dialing and obtains one 64-bit-long IPv6 address prefix from a network side, the wireless device first setting apart a 126-bit IPv6 address prefix from the prefix, and then allocating the 126-bit IPv6 address prefix to a WAN interface, allocating the 64-bit-long IPv6 address prefix to a LAN interface, and notifying a user terminal connected to the LAN interface of the IPv6 prefix of the LAN interface, so that the user terminal connected to the LAN interface generates its own IPv6 address through a stateless address auto-configuration mechanism for communication. With the technical solutions of the present document, in an IPv4/IPv6 dual stack mode, IPv4 and IPv6 protocol stacks operate normally, and the radio resource consumption is reduced.
摘要翻译：本文提供了一种基于单个IPv6地址前缀实现路由传输的方法和无线设备。该方法包括：当无线设备成功进行基于IPv6的拨号并从网络侧获取一个64位长的IPv6地址前缀时，无线设备首先从前缀中分离出126比特的IPv6地址前缀，然后分配向WAN接口提供126位IPv6地址前缀，将64位长的IPv6地址前缀分配给LAN接口，并将连接到LAN接口的用户终端通知LAN接口的IPv6前缀，以便用户连接到LAN接口的终端通过无状态地址自动配置机制生成自己的IPv6地址进行通信。通过本文档的技术方案，在IPv4 / IPv6双栈模式下，IPv4和IPv6协议栈运行正常，无线资源消耗减少。

2. 发明申请

US20140215087A1 Method for Route Transmission Based on Single IPv6 Address Prefix, and Wireless Device 有权
标题翻译：基于单IPv6地址前缀的路由传输方法和无线设备
公开(公告)号：US20140215087A1
公开(公告)日：2014-07-31
申请号：US14241989
申请日：2012-02-17
申请人： Li Zhao , Tao Lu , Jianfeng Li , Xiaoliang Ma
发明人： Li Zhao , Tao Lu , Jianfeng Li , Xiaoliang Ma
IPC分类号： H04W8/26 , H04W80/04 , H04W84/18 , H04L29/12 , H04L29/06
CPC分类号： H04W8/26 , H04L45/74 , H04L61/2007 , H04L61/25 , H04L61/6004 , H04L61/6022 , H04L61/6059 , H04L61/6068 , H04L61/6077 , H04L61/6086 , H04L69/16 , H04W40/24 , H04W80/04 , H04W84/18
摘要： The present document provides a method and wireless device for implementing route transmission based on a single IPv6 address prefix. The method includes: when a wireless device succeeds in IPv6-based dialing and obtains one 64-bit-long IPv6 address prefix from a network side, the wireless device first setting apart a 126-bit IPv6 address prefix from the prefix, and then allocating the 126-bit IPv6 address prefix to a WAN interface, allocating the 64-bit-long IPv6 address prefix to a LAN interface, and notifying a user terminal connected to the LAN interface of the IPv6 prefix of the LAN interface, so that the user terminal connected to the LAN interface generates its own IPv6 address through a stateless address auto-configuration mechanism for communication. With the technical solutions of the present document, in an IPv4/IPv6 dual stack mode, IPv4 and IPv6 protocol stacks operate normally, and the radio resource consumption is reduced.
摘要翻译：本文提供了一种基于单个IPv6地址前缀实现路由传输的方法和无线设备。该方法包括：当无线设备成功进行基于IPv6的拨号，并从网络侧获取一个64位长的IPv6地址前缀时，无线设备首先从前缀中分离出126比特的IPv6地址前缀，然后分配向WAN接口提供126位IPv6地址前缀，将64位长的IPv6地址前缀分配给LAN接口，并将连接到LAN接口的用户终端通知LAN接口的IPv6前缀，以便用户连接到LAN接口的终端通过无状态地址自动配置机制生成自己的IPv6地址进行通信。通过本文档的技术方案，在IPv4 / IPv6双栈模式下，IPv4和IPv6协议栈运行正常，无线资源消耗减少。

3. 外观设计

USD974868S1 Nail drill 有权
公开(公告)号：USD974868S1
公开(公告)日：2023-01-10
申请号：US29842240
申请日：2022-06-10
申请人： Jianfeng Li
设计人： Jianfeng Li

4. 发明授权

US09249084B2 Substituted n-pentanamide compounds, preparation method and the use thereof 有权
标题翻译：取代的正戊酰胺化合物，其制备方法及其用途
公开(公告)号：US09249084B2
公开(公告)日：2016-02-02
申请号：US13982733
申请日：2012-01-31
申请人： Qiang Zhang , Rongxia Zhang , Guanghui Tian , Jianfeng Li , Fuqiang Zhu , Xiangrui Jiang , Jingshan Shen
发明人： Qiang Zhang , Rongxia Zhang , Guanghui Tian , Jianfeng Li , Fuqiang Zhu , Xiangrui Jiang , Jingshan Shen
IPC分类号： C07C213/02 , C07C59/64 , C07C235/34 , C07C309/75 , C07C309/66 , C07C43/225 , C07D263/26 , C07C17/16 , C07C215/54 , C07C217/62 , C07C309/73 , C07D263/52 , C07C43/23 , C07C59/68 , C07C41/26
CPC分类号： C07C235/34 , C07C17/16 , C07C41/26 , C07C43/225 , C07C43/23 , C07C59/64 , C07C59/68 , C07C213/02 , C07C215/54 , C07C217/62 , C07C309/66 , C07C309/73 , C07C309/75 , C07D263/26 , C07D263/52 , Y02P20/582 , C07C22/04
摘要： The present invention relates to a (2R,3R)-3-(3-substituted phenyl)-2-methyl n-pentanamide compounds as shown in the formula I and the preparation method thereof, wherein, the substituents are as defined in the specification, the present invention further relates to a use of the above compounds for the preparation of tapentadol II or its pharmaceutically acceptable salt, and the intermediates involved in the preparation process.
摘要翻译：本发明涉及式I所示的（2R，3R）-3-（3-取代苯基）-2-甲基正戊酰胺化合物及其制备方法，其中取代基如本说明书中所定义，本发明还涉及上述化合物在制备他喷他多II或其药学上可接受的盐中的用途，以及参与制备方法的中间体。

5. 发明授权

US09062057B2 CCR5 antagonists for treating HIV 有权
标题翻译：用于治疗HIV的CCR5拮抗剂
公开(公告)号：US09062057B2
公开(公告)日：2015-06-23
申请号：US13635749
申请日：2011-03-18
申请人： Arun K. Ghosh , Hiroaki Mitsuya , Venkateswararao Kalapala , Jianfeng Li
发明人： Arun K. Ghosh , Hiroaki Mitsuya , Venkateswararao Kalapala , Jianfeng Li
IPC分类号： C07D471/04 , C07D487/04 , C07D493/04 , C07D451/04 , C07D221/20 , C07D519/00
CPC分类号： C07D487/04 , C07D221/20 , C07D451/04 , C07D471/04 , C07D493/04 , C07D519/00
摘要： Compounds that modulate the CCR5 chemokine receptor, pharmaceutical compositions containing them, and uses therefor in the treatment of HIV and related diseases are described.
摘要翻译：描述了调节CCR5趋化因子受体的化合物，含有它们的药物组合物及其用于治疗HIV和相关疾病的用途。

6. 发明授权

US08481741B2 Preparation methods of 6 substituted amino-3 cyanoquinoline compounds and the intermediates thereof 有权
标题翻译： 6取代氨基-3-氰基喹啉化合物的制备方法及其中间体
公开(公告)号：US08481741B2
公开(公告)日：2013-07-09
申请号：US13125721
申请日：2009-10-23
申请人： Yongjun Mao , Jianfeng Li , Jin Zheng , Zheng Liu , Kai Xie , Haihong Li , Jing Shi , Ye Li , Jingshan Shen
发明人： Yongjun Mao , Jianfeng Li , Jin Zheng , Zheng Liu , Kai Xie , Haihong Li , Jing Shi , Ye Li , Jingshan Shen
IPC分类号： C07D215/38
CPC分类号： C07C229/64 , C07C237/30 , C07C255/30 , C07D215/56
摘要： The present invention relates to a method for preparing 6-substituted amino-3-cyanoquinoline compounds (compound A for short) and the intermediates thereof, more particularly, to a compound of the following formula (I), the preparation method thereof, the intermediates thereof and use thereof for preparing the compound A. The compound of the formula (I) is cyclized in the presence of an alkali to give a compound of formula A, wherein W is OH; or the compound of the formula (I) is cyclized in the presence of an alkali, and then chlorinated to give a compound of the formula A, wherein W is Cl. Compared with the known methods in the literature, the method for preparing the compound A from the compound of formula (I) according to the present invention can avoid using high-temperature condition and high boiling point solvents, and is safe and environment-friendly, mild in reaction condition, easy in operation with a high yield and high product purity.
摘要翻译：本发明涉及一种制备6-取代氨基-3-氰基喹啉化合物（简称为化合物A）的方法及其中间体，更具体地涉及下式（I）的化合物，其制备方法，中间体及其用于制备化合物A的用途。式（I）化合物在碱存在下环化，得到式A化合物，其中W为OH; 或式（I）化合物在碱的存在下环化，然后氯化，得到式A化合物，其中W为Cl。与文献中已知的方法相比，本发明的式（I）化合物制备化合物A的方法可以避免使用高温条件和高沸点溶剂，且安全环保，反应条件温和，易于操作，产率高，产品纯度高。

7. 发明申请

US20080187224A1 Face Component Replacement 有权
标题翻译：面部组件更换
公开(公告)号：US20080187224A1
公开(公告)日：2008-08-07
申请号：US11670963
申请日：2007-02-03
申请人： Jin Wang , Jianfeng Li , Huaqui Zhang , Guogang Wang
发明人： Jin Wang , Jianfeng Li , Huaqui Zhang , Guogang Wang
IPC分类号： G06K9/46
CPC分类号： G06T11/60
摘要： A method is provided for cloning a facial feature template image into an original image including a face to form a new image. The method includes detecting the face and facial features in the original image, reducing the original and the template images, cloning the reduced template image into the reduced original image to form a new image, enlarging the new image, and displaying the enlarged new image. The method may use Poisson cloning where a resulting system of linear equations is solved by applying a Thomas algorithm to determine an initial solution and applying a Conjugate Gradient algorithm using the initial solution to determine a final solution to the system of linear equations.
摘要翻译：提供了一种将面部特征模板图像克隆成包括脸部的原始图像以形成新图像的方法。该方法包括检测原始图像中的面部和面部特征，减少原始图像和模板图像，将缩小的模板图像克隆到缩小的原始图像中，形成新图像，放大新图像，并显示放大的新图像。该方法可以使用泊松克隆，其中通过应用Thomas算法来求解所得到的线性方程式的系统来确定初始解，并使用初始解来应用共轭梯度算法来确定线性方程组的最终解。

8. 发明授权

US09527849B2 Salt and polymorph of pyrazolopyrimidinone compound, and pharmaceutical composition containing the same, preparation method and use thereof 有权
标题翻译：吡唑并嘧啶酮化合物的盐和多晶型物，以及含有它们的药物组合物，其制备方法和用途
公开(公告)号：US09527849B2
公开(公告)日：2016-12-27
申请号：US14238790
申请日：2012-08-14
申请人： Jianfeng Li , Guanghui Tian , Zhen Wang , Jin Suo , Xiangrui Jiang , Zheng Liu , Xiaojun Yang , Zhu Xie , Xianguo Zhao , Weiliang Zhu , Hualiang Jiang , Jingshan Shen
发明人： Jianfeng Li , Guanghui Tian , Zhen Wang , Jin Suo , Xiangrui Jiang , Zheng Liu , Xiaojun Yang , Zhu Xie , Xianguo Zhao , Weiliang Zhu , Hualiang Jiang , Jingshan Shen
IPC分类号： C07D487/04 , A61K31/519 , A61P15/10 , A61P13/10 , A61P9/10 , A61P9/04 , A61P13/12 , A61P11/06 , A61P29/00 , A61P27/06 , A61P9/12
CPC分类号： C07D487/04 , C07B2200/13
摘要： The present invention relates to new salts of pyrazolopyrimidinone represented by formula (I), and pharmaceutically acceptable polymorph, solvate, hydrate, dehydrate, co-crystallization, anhydrous, or amorphous form thereof, the pharmaceutical compositions, and a pharmaceutical unit dosage form containing the same, wherein x represents organic or inorganic acids, preferable maleic acid, succinic acid, methanesulfonic acid, hydrochloric acid, etc. The invention further relates to co-crystals or complexes of compounds of pyrazolopyrimidinone and pharmaceutical compositions containing the same. The present invention also relates to a process for the preparation, use thereof and pharmaceutical preparation containing the salts or crystalline forms.
摘要翻译：本发明涉及由式（I）表示的吡唑并嘧啶酮的新盐及其药学上可接受的多晶型物，溶剂化物，水合物，脱水，共结晶，无水或无定形形式，药物组合物和含有相同的，其中x表示有机或无机酸，优选的马来酸，琥珀酸，甲磺酸，盐酸等。本发明还涉及吡唑并嘧啶酮化合物的共晶或络合物和含有它们的药物组合物。本发明还涉及其制备方法，使用方法和含有盐或结晶形式的药物制剂。

9. 发明授权

US08985372B2 Slow cooker and locking assembly 有权
标题翻译：慢炖锅和锁紧组件
公开(公告)号：US08985372B2
公开(公告)日：2015-03-24
申请号：US13659033
申请日：2012-10-24
申请人： Guoqing Yang , Jianfeng Li , Jinshui Wu , Pingtao Chen
发明人： Guoqing Yang , Jianfeng Li , Jinshui Wu , Pingtao Chen
IPC分类号： B65D45/00 , B65D45/28 , B65D45/16 , A47J27/08 , A47J36/10
CPC分类号： A47J36/10 , A47J27/0811 , B65D25/28 , B65D2525/283
摘要： The present invention relates to cooking utensils. The present invention provides a slow cooker and a locking assembly that have simple and practical structure, easy to clean and can engage the lid with the liner container for preventing spillage of cooking content such as soup. The structure comprises a container, a lid and a locking assembly. The locking assembly retains the lid on the opening of the container. The container has a rim projecting outside at the opening. The locking assembly comprises a connector disposed on the lid for engaging the lid with the opening of the container, and locking end components provided at ends of the connector for engaging with the rim of the liner container. Using the locking assembly to retain the lid in sealing engagement with the opening of the container, the slow cooker can effectively engage the lid with the container.
摘要翻译：本发明涉及炊具。本发明提供了一种具有简单实用的结构，容易清洁并可与盖体接合的缓慢烹调器和锁定组件，用于防止诸如汤的蒸煮物质的溢出。该结构包括容器，盖子和锁定组件。锁定组件将盖子保持在容器的开口上。容器具有在开口处向外突出的边缘。锁定组件包括设置在盖上的连接器，用于将盖与容器的开口接合，以及设置在连接器的端部处的锁定端部部件，用于与衬套容器的边缘接合。使用锁定组件来将盖保持与容器的开口密封接合，慢炖锅可以有效地将盖与容器接合。

10. 发明申请

US20120277448A1 PREPARATION METHOD FOR 3BETA-ARACHIDYLAMIDO-7ALPHA, 12ALPHA, 5BETA-CHOLAN-24-CARBOXYLIC ACID 审中-公开
标题翻译： 3BETA-ARACHIDYLAMIDO-7ALPHA，12ALPHA，5BETA-CHOLAN-24-羧酸的制备方法
公开(公告)号：US20120277448A1
公开(公告)日：2012-11-01
申请号：US13520117
申请日：2010-11-25
申请人： Xiangrui Jiang , Lijun Guo , Yiru Dai , Jianfeng Li , Jin Suo , Rongxia Zhang , Zheng Liu
发明人： Xiangrui Jiang , Lijun Guo , Yiru Dai , Jianfeng Li , Jin Suo , Rongxia Zhang , Zheng Liu
IPC分类号： C07J41/00 , C07J9/00
CPC分类号： C07J41/0011 , C07J9/005 , C07J31/006 , C07J41/0005 , C07J41/0027 , Y02P20/55
摘要： A method for preparing 3β-arachidylamido-7α,12α,5β-cholan-24-carboxylic acid represented by the following formula V is disclosed, which includes the following steps: converting cholic acid to the compound of formula III by acylation reaction and azidation reaction, reducing the compound of formula III to the compound of formula IV and in the end acylating the compound of formula IV with arachidoyl chloride to get the compound of formula V. The method avoids the use of protection groups.
摘要翻译：公开了一种制备由下式V表示的3'- bgr-酰胺基酰胺基-7α，12α，5'- b-胆碱-24-羧酸的方法，其包括以下步骤：通过酰化反应将胆酸转化为式III化合物，叠氮化反应，将式III化合物还原成式Ⅳ化合物，最后用芳ido酰氯酰化式Ⅳ化合物，得到式Ⅴ化合物。该方法避免使用保护基团。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式